110 related articles for article (PubMed ID: 8470282)
1. Inhibition of graft arteriosclerosis by modulation of the inflammatory response.
Adams DH; Wyner LR; Steinbeck MJ; Karnovsky MJ
Transplant Proc; 1993 Apr; 25(2):2092-4. PubMed ID: 8470282
[No Abstract] [Full Text] [Related]
2. Cardiac graft arteriosclerosis in the rat.
Adams DH; Wyner LR; Karnovsky MJ
Transplant Proc; 1993 Apr; 25(2):2071-3. PubMed ID: 8470275
[No Abstract] [Full Text] [Related]
3. Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899
[No Abstract] [Full Text] [Related]
4. Altered expression of smooth muscle and non-muscle myosin heavy chain isoforms in rejected hearts: a sensitive marker for acute rejection and graft coronary arteriosclerosis.
Suzuki J; Aikawa M; Isobe M; Sekiguchi M; Yazaki Y; Nagai R
Transplant Proc; 1995 Feb; 27(1):578. PubMed ID: 7879106
[No Abstract] [Full Text] [Related]
5. Efficacy of cyclosporine and angiotensin-converting enzyme inhibitor to inhibit cardiac graft atherosclerosis in the rat.
Paul LC; Davidoff A; Benediktsson H
Transplant Proc; 1994 Oct; 26(5):2873-4. PubMed ID: 7940907
[No Abstract] [Full Text] [Related]
6. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
[No Abstract] [Full Text] [Related]
7. Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression.
D'Silva M; DeRoover A; Nishimura Y; Antoniou E; Candinas D; Hubscher SG; McMaster P
Transplant Proc; 1996 Apr; 28(2):948-9. PubMed ID: 8623475
[No Abstract] [Full Text] [Related]
8. The failure of donor essential fatty acid deficiency to prevent renal allograft rejection in rats.
Lawen JG; Yu W; Cook HW; Wright JR
Transplantation; 1993 Nov; 56(5):1269-70. PubMed ID: 8249137
[No Abstract] [Full Text] [Related]
9. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model.
Meiser BM; Wenke K; Thiery J; Wolf S; Devens C; Seidel D; Hammer C; Billingham ME; Reichart B
Transplant Proc; 1993 Apr; 25(2):2077-9. PubMed ID: 7682363
[No Abstract] [Full Text] [Related]
10. Nonimmune factors may contribute to chronic rejection of kidney transplants.
Azuma H; Tullius SG; Heemann UW; Tilney NL
Transplant Proc; 1994 Aug; 26(4):2109-10. PubMed ID: 8066686
[No Abstract] [Full Text] [Related]
11. Long-term n-3 polyunsaturated fatty acids administration ameliorates arteriosclerosis by modulating T-cell activity in a rat model of small intestine transplantation.
Wang J; Ma H; Wang J; Li Q; Li Y; Li J
Clin Chim Acta; 2007 Jun; 381(2):124-30. PubMed ID: 17395171
[TBL] [Abstract][Full Text] [Related]
12. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
[No Abstract] [Full Text] [Related]
13. Effect of hemodynamics on graft rejection in the heterotopic heart transplantation model.
Lange V; Gassel AM; Deuse T; Ulrichs K; Silber RE
Transplant Proc; 1998 Jun; 30(4):1014-6. PubMed ID: 9636410
[No Abstract] [Full Text] [Related]
14. Macrophages and transplant arteriosclerosis: known and novel molecules.
Russell ME
J Heart Lung Transplant; 1995; 14(6 Pt 2):S111-5. PubMed ID: 8719472
[No Abstract] [Full Text] [Related]
15. Modulation of inflammatory activation pathways in the Lewis-to-F-344 rat chronic cardiac rejection model.
Russell ME; Hancock WW; Wallace AF; Wyner LR; Karnovsky MJ
Transplant Proc; 1995 Jun; 27(3):2100-4. PubMed ID: 7792898
[No Abstract] [Full Text] [Related]
16. FK 506 inhibits the development of transplant arteriosclerosis.
Wu GD; Cramer DV; Chapman FA; Cajulis E; Wang HK; Starzl TE; Makowka L
Transplant Proc; 1991 Dec; 23(6):3272-4. PubMed ID: 1721433
[No Abstract] [Full Text] [Related]
17. Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously.
Lowry RP; Takeuchi T; Cremisi H; Konieczny B; Someren A
Transplant Proc; 1993 Apr; 25(2):2103-5. PubMed ID: 8470286
[No Abstract] [Full Text] [Related]
18. Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation.
Silber RE; Lange V; Gassel AM; Ulrichs K
Transplant Proc; 1998 Jun; 30(4):987-8. PubMed ID: 9636398
[No Abstract] [Full Text] [Related]
19. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of poly(ADP-ribose) polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection.
Szabó G; Bährle S; Sivanandam V; Stumpf N; Gerö D; Berger I; Beller C; Hagl S; Szabó C; Dengler TJ
J Heart Lung Transplant; 2006 Jul; 25(7):794-804. PubMed ID: 16818122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
